C

Caregen Co Ltd
KOSDAQ:214370

Watchlist Manager
Caregen Co Ltd
KOSDAQ:214370
Watchlist
Price: 33 000 KRW -3.37% Market Closed
Market Cap: 1.8T KRW
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+17%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

Price Targets Summary
Caregen Co Ltd

Wall Street analysts forecast Caregen Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Caregen Co Ltd is 38 760 KRW with a low forecast of 38 380 KRW and a high forecast of 39 900 KRW.

Lowest Forecast
Wall Street Target
38 380 KRW
16% Upside
Average Forecast
Wall Street Target
38 760 KRW
17% Upside
Highest Forecast
Wall Street Target
39 900 KRW
21% Upside
Lowest
Price Target
38 380 KRW
16% Upside
Average
Price Target
38 760 KRW
17% Upside
Highest
Price Target
39 900 KRW
21% Upside
Caregen Co Ltd Competitors:
Price Targets
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
5% Upside
ALM
Almirall SA
18% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
28% Upside
128940
Hanmi Pharm Co Ltd
20% Upside
600196
Shanghai Fosun Pharmaceutical Group Co Ltd
5% Upside
ALM
Almirall SA
18% Upside
A
300452
Anhui Sunhere Pharmaceutical Excipients Co Ltd
28% Upside
128940
Hanmi Pharm Co Ltd
20% Upside
APLLTD
Alembic Pharmaceuticals Ltd
3% Upside
CRON
Cronos Group Inc
9% Downside

Revenue
Forecast

Revenue Estimate
Caregen Co Ltd

For the last 11 years the compound annual growth rate for Caregen Co Ltd's revenue is 13%. The projected CAGR for the next 2 years is 21%.

13%
Past Growth
21%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Caregen Co Ltd

For the last 11 years the compound annual growth rate for Caregen Co Ltd's operating income is 13%. The projected CAGR for the next 2 years is 43%.

13%
Past Growth
43%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Caregen Co Ltd

For the last 11 years the compound annual growth rate for Caregen Co Ltd's net income is 13%. The projected CAGR for the next 2 years is 45%.

13%
Past Growth
45%
Estimated Growth
Estimates Accuracy
-14%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Caregen Co Ltd's stock price target?
Price Target
38 760 KRW

According to Wall Street analysts, the average 1-year price target for Caregen Co Ltd is 38 760 KRW with a low forecast of 38 380 KRW and a high forecast of 39 900 KRW.

What is Caregen Co Ltd's Revenue forecast?
Projected CAGR
21%

For the last 11 years the compound annual growth rate for Caregen Co Ltd's revenue is 13%. The projected CAGR for the next 2 years is 21%.

What is Caregen Co Ltd's Operating Income forecast?
Projected CAGR
43%

For the last 11 years the compound annual growth rate for Caregen Co Ltd's operating income is 13%. The projected CAGR for the next 2 years is 43%.

What is Caregen Co Ltd's Net Income forecast?
Projected CAGR
45%

For the last 11 years the compound annual growth rate for Caregen Co Ltd's net income is 13%. The projected CAGR for the next 2 years is 45%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.